Switzerland startup funding in H1 2014
European tech funding raised by Switzerland startups during H1 2014.
In H1 2014, 26 startups in Switzerland closed 27 funding rounds and raised €156M in equity funding (excluding debt and grants), up 88.0% versus H1 2013. Debt rounds added €7.7M. Healthtech was the most active sector, and Swisscom Ventures was the most active investor. Data as of 6 Nov 2026.
Equity funding
€156M
+88.0% vs H1 2013 · excl. debt & grants · +€7.7M debt
Funding rounds
27
+68.8% vs H1 2013
Companies
26
Top sector
Healthtech
Rank in Europe
#8
4.0% of European funding
Debt financing
€7.7M
4.6% of total
Top-10 round share
92.6%
of disclosed capital
Funding by month
€ raised vs rounds, by monthSwitzerland — funding by month, H1 2014 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €19M | 2 |
| Feb | €50M | 5 |
| Mar | €4.2M | 3 |
| Apr | €53M | 8 |
| May | €30M | 3 |
| Jun | €9.1M | 6 |
Top sectors
by € raisedSwitzerland — top sectors by capital, H1 2014 — interactive chart.
Data table
| Switzerland — top sectors by capital, H1 2014 | |
|---|---|
| Healthtech | €119M |
| Cybersecurity | €24M |
| Telecom | €22M |
| Software | €15M |
| Deeptech | €4.0M |
| Marketing | €2.2M |
| Hardware | €1.5M |
| Travel | €1.2M |
Stage mix
by € raisedSwitzerland — stage mix, H1 2014 — interactive chart.
Data table
| Switzerland — stage mix, H1 2014 | |
|---|---|
| Series D+ | €67M |
| Growth/Late | €27M |
| Series A | €25M |
| Series C | €17M |
| Series B | €8.4M |
| Debt | €7.7M |
| Early VC | €6.5M |
| Seed | €4.4M |
| Grant | €1.7M |
| Other | €1.5M |
Top deals
largest disclosed rounds in H1 2014| Company | Stage | Date | Amount |
|---|---|---|---|
| NovImmune | Series D+ | Feb 2014 | €49M |
| CRISPR Therapeutics | Series A | Apr 2014 | €23M |
| Silent Circle | Growth/Late | May 2014 | €22M |
| AC Immune | Series D+ | Jan 2014 | €18M |
| Sequana Medical | Series C | Apr 2014 | €17M |
| beqom | Debt | Apr 2014 | €7.7M |
| Aleva Neurotherapeutics | Series B | May 2014 | €5.8M |
| Nexthink | Growth/Late | Jun 2014 | €5.1M |
| Scandit | Early VC | Mar 2014 | €4.0M |
| ProteoMediX | Series B | Apr 2014 | €2.6M |
| Nanolive | Early VC | Apr 2014 | €2.5M |
| Tresorit | Series A | May 2014 | €2.2M |
| Biocartis | Grant | Jun 2014 | €1.7M |
| dizmo | Other | Jun 2014 | €1.5M |
| Endignorance | Seed | Jan 2014 | €885k |
Top investors
most active in H1 2014, by deal count- Swisscom Ventures2 deals
- EntrePREneurs Fund1 deals
- Euroventures Capital Advisory1 deals
- Life Sciences Partners1 deals
- Marcus Bonalumi1 deals
- NeoMed1 deals
- Omar Bawa1 deals
- Redalpine1 deals
- Rosetta Capital1 deals
- SevenVentures1 deals